Press release
Parkinsons Disease Treatment Market: Booming Key Players GlaxoSmithKline Plc, Merck KGaA, Novartis AG, Bausch Health, AbbVie Inc.
Parkinsons disease is one of the progressive nervous system disorder that affects the movement of individuals. The symptoms of Parkinsons starts gradually with a barely noticeable tremors in one hand. The further symptoms of the disease usually leads to stiffness, rigid muscles, impaired posture and balance, loss of automatic movement, and slowing of movement. Parkinsons disease cannot be completely cured, however, the medications helps to improve the symptoms of the disease.Get sample PDF copy @ https://bit.ly/3b5Ha2X
The key players influencing the market are:
GlaxoSmithKline Plc
Merck KGaA
Novartis AG
Teva Pharmaceutical Industries Ltd.
Boehringer Ingelheim GmbH
Bausch Health
H. Lundbeck A/S
Sun Pharmaceutical Industries Ltd
AbbVie Inc.
Impax Laboratories, LLC
The Parkinsons disease treatment market is anticipated to grow in the forecast, owing to the factors such as increasing geriatric population, government funding for Parkinsons disease treatment research and new product launches. In addition, initiatives undertaken by various government and non-government organizations as well as a promising pipeline of the disease medications is expected to offer significant growth opportunities in the market during the forecast period.
The "Global Parkinsons Disease Treatment Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of Parkinsons disease treatment market with detailed market segmentation by drug class, distribution channel and geography. The global Parkinsons disease treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Parkinsons disease treatment market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Parkinsons disease treatment market is segmented on the basis of drug class, distribution channel and geography. Based on type, the market is segmented as carbidopa/levodopa, dopamine receptor agonists, Mao inhibitors, comt inhibitors, anticholinergic and other drugs. On the basis of distribution channel, the global Parkinsons disease treatment market is segmented into, hospital pharmacies, retail pharmacies, and online pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Parkinsons disease treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Parkinsons disease treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Parkinsons Disease Treatment Market - By Drug Class
1.3.2 Parkinsons Disease Treatment Market - By Distribution Channel
1.3.3 Parkinsons Disease Treatment Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. PARKINSONS DISEASE TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PARKINSONS DISEASE TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. PARKINSONS DISEASE TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. PARKINSONS DISEASE TREATMENT - GLOBAL MARKET OVERVIEW
6.2. PARKINSONS DISEASE TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
Purchase This Report @ https://bit.ly/35wJf6W
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Semiconductors, Healthcare, Manufacturing, Automotive and Defense.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Parkinsons Disease Treatment Market: Booming Key Players GlaxoSmithKline Plc, Merck KGaA, Novartis AG, Bausch Health, AbbVie Inc. here
News-ID: 2034555 • Views: …
More Releases from The Insight Partners
Top Poultry Diagnostics Companies Analysis By 2030
The poultry diagnostics market size is expected to grow from US$ 362.90 million in 2022 to US$ 792.70 million by 2030; the market is estimated to register a CAGR of 10.3% from 2022 to 2030.
Download PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003535?utm_source=OpenPR&utm_medium=10379
The List of Companies
• Thermo Fisher Scientific Inc
• Idexx Laboratories Inc
• Qiagen NV
• Eurofins Scientific SE
• IDVET
• Boehringer Ingelheim International GmbH
• Zoetis Inc
• BioCheck BV
• Bioneer Corp
• BioInGenTech Biotechnologies
By Test Type
• Enzyme-Linked Immunosorbent Assay Tests
• Polymerase Chain Reaction Test
• Hemagglutination-Inhibition
By Disease
• Avian Salmonellosis
• Avian…
Top Mesotherapy Companies Analysis By 2031
The mesotherapy market size is projected to reach US$ 1,317.05 million by 2031 from US$ 664.13 million in 2024. The market is expected to register a CAGR of 10.4% during 2025-2031.
Download PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00015280?utm_source=OpenPR&utm_medium=10379
The List of Companies
• Koru Pharma Co Ltd
• Institute BCN Esthetics SL
• Mesoskinline ApS
• HB Aesthetics Group SA
• Toskani SL
• Dr. Korman Laboratories Ltd
• Revitacare SAS
• Mesoestetic E-Commerce SL
• Galderma SA
• Derm Beauty International Sdn Bhd
By Product
• Mesotherapy Solution Kits
• Mesotherapy Devices
• Mesotherapy Fillers Kits
• Mesotherapy Chemical…
Top Bioinformatics Services Companies Analysis By 2031
The Bioinformatics Services Market is expected to register a CAGR of 15.3% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
Download PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00006884?utm_source=OpenPR&utm_medium=10379
The List of Companies
• Thermo Fisher Scientific Inc.
• Illumina, Inc
• PerkinElmer, Inc.
• BGI
• Source BioScience
• QIAGEN
• CD Genomics
• GENEWIZ
• BaseClear B.V.
By Type
• Data Analysis
• Sequencing Services
• Drug Discovery Services
• Gene Expression Analysis
• Database and Management Services
• Others
By Specialty
• Medical Biotechnology
• Plant Biotechnology
• Animal Biotechnology
• Forensic Biotechnology
• Environmental Biotechnology
About US
The Insight Partners is…
A Complete Study Guide to RF Front End Module
RF front end modules are widely used in devices such as smartphones, tablets, Wi-Fi routers, IoT devices, and other wireless communication systems to ensure that RF signals are handled efficiently and effectively. RF front-end modules simplify the design process of device manufacturers as it is pre-engineered to handle complex RF signal management and reduce the need for extensive RF design expertise. Increasing demand for high data rates, growing applications in…
More Releases for Parkinsons
Ibogaine By David Dardashti Offers a Solution to Parkinsons
Ibogaine By David Dardashti today announced that preliminary research suggests ibogaine, a naturally occurring psychoactive alkaloid found in the root bark of the Tabernanthe iboga plant, may hold potential for treating Parkinson's disease. While some studies indicate ibogaine could impact the neurotransmitter systems involved in Parkinson's, the organization emphasizes the need for significantly more research to fully understand its effects and potential risks.
Parkinson's disease is a chronic and progressive neurodegenerative…
Parkinsons Disease Market to Significant Growth by 2030
Acumen Research and Consulting has announced the addition of the "Parkinson's Disease Market" report to their offering.
The Parkinson's Disease Market Report 2030 is an in depth study analyzing the current state of the Parkinson's Disease Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Parkinson's Disease Market provides analysis of global market covering the industry trends, recent…
Asia-Pacific Parkinsons Disease Drugs Market Report 2017
MarketResearchReports.Biz presents this most up-to-date research on "Asia-Pacific Parkinsons Disease Drugs Market Report 2017"
Description
In this report, the Asia-Pacific Parkinsons Disease Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share…
Global Parkinsons Disease Market Report: 2016 Edition
Parkinsons Disease (PD) is a chronic and progressive neurodegenerative or movement disorder which involves the malfunction and death of vital nerve cells in the brain, called neurons. Parkinsons primarily affects neurons in an area of the brain called the “substantia nigra”. The early signs and symptoms may be mild and may go unnoticed initially. The cause of this disease is mainly unknown with no cure till date but there exist…
Parkinsons Disease Industry : Insights, Development, Research and Forecast 2017
Albany, NY, 21st FEB : Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties, and progress in varying stages.
Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=970727
There is currently no cure for PD,…
Parkinsons Disease Market Research Report - Heat Map and Analysis
Albany, New York, February 15, 2017: Market Research Hub has recently announced the addition of a new report to it broad database titled as “Parkinsons Disease - Heat Map and Analysis”. Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment.
Request for Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=970727
PD is an age-related disorder; symptoms typically begin…
